Status:
COMPLETED
A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation
Lead Sponsor:
University of Pennsylvania
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to examine the overall effectiveness of anti-arrhythmic medicines (to control heart rhythm) prescribed after an ablation procedure for atrial fibrillation.
Detailed Description
Atrial fibrillation (AF) is the most common heart rhythm disorder in the US and it is associated with shortness of breath, palpitations, stroke occurrence and increased mortality. Traditional treatmen...
Eligibility Criteria
Inclusion
- Adult patients meeting ACC/AHA criteria for paroxysmal atrial fibrillation (episodes typically last no more than 7 days and are self-terminating)
- Eligible for pulmonary vein isolation
- Able to tolerate antiarrhythmic medication
Exclusion
- Age \<18
- Persistent or permanent atrial fibrillation (episodes last \>7 days and require cardioversion)
- Antiarrhythmic treatment for indication other than atrial fibrillation
- Contraindication or intolerance to all antiarrhythmic medications
- Primary physician unwilling to withhold antiarrhythmic drugs for duration of the study
- Failure to obtain informed consent
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00408200
Start Date
November 1 2006
End Date
June 1 2008
Last Update
March 7 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
2
Presbyterian Medical Center
Philadelphia, Pennsylvania, United States, 19104